postherpetic neuralgia
Neuropathic Pain Study Finds Decreased Opioid Utilization With 1.8% Lidocaine Patch
New retrospective claims data showed that the lidocaine topical system 1.8% patch was associated with less use of ...
DECEMBER 27, 2024
Guideline Review Emphasizes Multidisciplinary Approach to Rehabilitation for Neuropathic Pain
An international review of guidelines for rehabilitative intervention in neuropathic pain found a common emphasis ...
MAY 13, 2021
FDA Approves Lidocaine Transdermal System for Postherpetic Neuralgia Pain
The FDA approved a 1.8% lidocaine topical system (ZTlido, Scilex) for the relief of pain associated with ...
MARCH 2, 2018
CDC’s ACIP Recommends Adding Shingrix to the Adult Vaccination Schedule
The committee voted to include Shingrix (GlaxoSmithKline) in the adult vaccination recommendations for to prevent ...
OCTOBER 27, 2017
Zoster Vaccine Reduces Serious Shingles Complications in Seniors, Yet Remains Underused
Despite the fact that Merck’s Zostavax shingles vaccine provides seniors with high rates of protection from ...
APRIL 20, 2017
Postherpetic Neuralgia: New Perspectives on Pathogenesis and Treatment
Despite the availability of a zoster vaccine, 1 in 3 individuals in the United States will develop zoster during ...
DECEMBER 24, 2015
